Change of CD20 Expression in Diffuse Large B-Cell Lymphoma Treated with Rituximab, an Anti-CD20 Monoclonal Antibody: A Study of the Osaka Lymphoma Study Group

Change of CD20 expression was examined in cases of diffuse large B-cell lymphoma (DLBCL). CD20 expression after treatment with anti-CD20 antibody (rituximab, Rx) for DLBCL was examined in 23 cases who received serial biopsy by immunohistochemistry (IHC) and flow cytometry (FCM). CD20– by IHC and/or...

Descripción completa

Detalles Bibliográficos
Autores principales: Wada, Naoki, Kohara, Masaharu, Ogawa, Hiroyasu, Sugiyama, Haruo, Fukuhara, Shirou, Tatsumi, Yoichi, Kanamaru, Akihisa, Hino, Masayuki, Kanakura, Yuzuru, Morii, Eiichi, Aozasa, Katsuyuki
Formato: Texto
Lenguaje:English
Publicado: S. Karger AG 2009
Materias:
Published: October 2009
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914382/
https://www.ncbi.nlm.nih.gov/pubmed/20737037
http://dx.doi.org/10.1159/000249152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914382/
https://www.ncbi.nlm.nih.gov/pubmed/20737037
http://dx.doi.org/10.1159/000249152

Ejemplares similares